Eikon Therapeutics discloses two board resignations effective July 31, 2026
The company said neither departure stemmed from a disagreement over its operations, policies, or practices.
Eikon Therapeutics, Inc. disclosed in an 8-K filing that Leon Chen, Ph.D. and Joshua Wolfe stepped down from the company's board of directors, effective July 31, 2026.1
The filing stated that the two resignations did not result from any dispute with the company concerning its operations, policies, or practices.1
The report was signed by Alfred Bowie, Ph.D., the company's Chief Financial Officer, and dated August 3, 2026. The filing did not name replacements for the two vacated board seats or provide further detail on the reasons for the departures.
Written by readthrough’s AI from the linked primary sources and fact-checked against them automatically before publishing. Not investment advice.